Table 1 Summary of patients’ clinical characteristics from 4b datasets.

From: Identification and validation of a prognostic risk-scoring model based on the level of TIM-3 expression in acute myeloid leukemia

Patient’s parameters

TCGA

GSE71014

GSE146173

GSE12417

Age, years/n(%)

 < 65

98(69.5)

172(69.9)

47(59.5)

 ≥ 65

43(30.5)

74(30.1)

32(40.5)

WBC, × 109/L/n(%)

 < 10

53(37.6)

103(41.9)

 ≥ 10

87(61.7)

143(58.1)

 NA

1(0.7)

 

PB blasts, %/n(%)

 < 40

16(11.3)

 ≥ 40

125(88.7)

BM blasts, %/n(%)

 < 50

88(62.4)

79(100)

 ≥ 50

53(37.6)

Risk/n(%)

 Favorable

30(21.3)

65(26.4)

 Intermediate/normal

77(54.6)

127(51.6)

 Poor

32(22.7)

46(18.7)

 NA

2(1.4)

8(3.2)

OS/n(%)

 Alive

52(36.9)

68(65.4)

97(39.4)

33(41.8)

 Dead

89(63.1)

36(34.6)

149(60.6)

46(58.2)

Survival rates, year/(%)

 1

56

52.9

62.2

59.5

 3

18.4

24

41.1

26.6

 5

5

14.4

8.1

AUC, year/(%)

 1

0.64

0.69

0.60

0.61

 3

0.74

0.64

0.57

0.61

 5

0.78

0.89

0.59

 Platform

GPL10558

IlluminaHiSeq 1500

GPL570

 Total

141

104

246

79